Literature DB >> 11954049

"Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect.

Nora D Volkow1, Gene-Jack Wang, Joanna S Fowler, Jean Logan, Millard Jayne, Dinko Franceschi, Cristopher Wong, Samuel J Gatley, Andrew N Gifford, Yu-Shin Ding, Naomi Pappas.   

Abstract

The drive for food is one of the most powerful of human and animal behaviors. Dopamine, a neurotransmitter involved with motivation and reward, its believed to regulate food intake in laboratory animals by modulating its rewarding effects through the nucleus accumbens (NA). Here we assess the involvement of dopamine in "nonhedonic" food motivation in humans. Changes in extracellular dopamine in striatum in response to nonhedonic food stimulation (display of food without consumption) were evaluated in 10 food-deprived subjects (16-20 h) using positron emission tomography (PET) and [11C]raclopride (a D2 receptor radioligand that competes with endogenous dopamine for binding to the receptor). To amplify the dopamine changes we pretreated subjects with methylphenidate (20 mg p.o.), a drug that blocks dopamine transporters (mechanism for removal of extracellular dopamine). Although the food stimulation when preceded by placebo did not increase dopamine or the desire for food, the food stimulation when preceded by methylphenidate (20 mg p.o.) did. The increases in extracellular dopamine were significant in dorsal (P < 0.005) but not in ventral striatum (area that included NA) and were significantly correlated with the increases in self-reports of hunger and desire for food (P < 0.01). These results provide the first evidence that dopamine in the dorsal striatum is involved in food motivation in humans that is distinct from its role in regulating reward through the NA. In addition it demonstrates the ability of methylphenidate to amplify weak dopamine signals. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11954049     DOI: 10.1002/syn.10075

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  131 in total

1.  Dorsal striatum responses to reward and punishment: effects of valence and magnitude manipulations.

Authors:  M R Delgado; H M Locke; V A Stenger; J A Fiez
Journal:  Cogn Affect Behav Neurosci       Date:  2003-03       Impact factor: 3.282

Review 2.  Dopamine-related frontostriatal abnormalities in obesity and binge-eating disorder: emerging evidence for developmental psychopathology.

Authors:  Michael Michaelides; Panayotis K Thanos; Nora D Volkow; Gene-Jack Wang
Journal:  Int Rev Psychiatry       Date:  2012-06

Review 3.  Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses.

Authors:  A C Reichelt; R F Westbrook; M J Morris
Journal:  Br J Pharmacol       Date:  2015-11-01       Impact factor: 8.739

4.  Pre-existing differences in motivation for food and sensitivity to cocaine-induced locomotion in obesity-prone rats.

Authors:  Peter J Vollbrecht; Cameron W Nobile; Aaron M Chadderdon; Emily M Jutkiewicz; Carrie R Ferrario
Journal:  Physiol Behav       Date:  2015-09-28

Review 5.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

Review 6.  Obesity and Brain Positron Emission Tomography.

Authors:  Kyoungjune Pak; Seong-Jang Kim; In Joo Kim
Journal:  Nucl Med Mol Imaging       Date:  2017-05-19

Review 7.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

Review 8.  Ventral pallidum roles in reward and motivation.

Authors:  Kyle S Smith; Amy J Tindell; J Wayne Aldridge; Kent C Berridge
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

9.  Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

Authors:  Nora D Volkow; Joanna S Fowler; Jean Logan; David Alexoff; Wei Zhu; Frank Telang; Gene-Jack Wang; Millard Jayne; Jacob M Hooker; Christopher Wong; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog-Torres
Journal:  JAMA       Date:  2009-03-18       Impact factor: 56.272

10.  Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.

Authors:  I Peraile; E Torres; A Mayado; M Izco; A Lopez-Jimenez; J A Lopez-Moreno; M I Colado; E O'Shea
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.